Seto M - Search Results

1

Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro.

Iqbal J, Weisenburger DD, Chowdhury A, Tsai MY, Srivastava G, Greiner TC, Kucuk C, Deffenbacher K, Vose J, Smith L, Au WY, Nakamura S, Seto M, Delabie J, Berger F, Loong F, Ko YH, Sng I, Liu X, Loughran TP, Armitage J, Chan WC; International Peripheral T-cell Lymphoma Project. Iqbal J, et al. Among authors: seto m. Leukemia. 2011 Feb;25(2):348-58. doi: 10.1038/leu.2010.255. Epub 2010 Nov 5. Leukemia. 2011. PMID: 21052088

2

Immunostaining of PRAD1/cyclin D1 protein as a marker for the diagnosis of mantle cell lymphoma.

Nakamura S, Yatabe Y, Kuroda H, Ueda R, Takahashi T, Suchi T, Seto M. Nakamura S, et al. Among authors: seto m. Leukemia. 1997 Apr;11 Suppl 3:536-7. Leukemia. 1997. PMID: 9209449

3

[Mantle cell lymphoma and related lesions].

Nakamura S, Seto M. Nakamura S, et al. Among authors: seto m. Rinsho Ketsueki. 1996 May;37(5):408-11. Rinsho Ketsueki. 1996. PMID: 8691585 Japanese. No abstract available.

4

Establishment of a follicular lymphoma cell line (FLK-1) dependent on follicular dendritic cell-like cell line HK.

Kagami Y, Jung J, Choi YS, Osumi K, Nakamura S, Morishima Y, Seto M. Kagami Y, et al. Among authors: seto m. Leukemia. 2001 Jan;15(1):148-56. doi: 10.1038/sj.leu.2402002. Leukemia. 2001. PMID: 11243383

5

Cyclin D1 overexpression in malignant lymphomas.

Nakamura S, Yatabe Y, Seto M. Nakamura S, et al. Among authors: seto m. Pathol Int. 1997 Jul;47(7):421-9. doi: 10.1111/j.1440-1827.1997.tb04519.x. Pathol Int. 1997. PMID: 9234379 Review.

6

Development and analysis of patient-derived xenograft mouse models in intravascular large B-cell lymphoma.

Shimada K, Shimada S, Sugimoto K, Nakatochi M, Suguro M, Hirakawa A, Hocking TD, Takeuchi I, Tokunaga T, Takagi Y, Sakamoto A, Aoki T, Naoe T, Nakamura S, Hayakawa F, Seto M, Tomita A, Kiyoi H. Shimada K, et al. Among authors: seto m. Leukemia. 2016 Jul;30(7):1568-79. doi: 10.1038/leu.2016.67. Epub 2016 Mar 22. Leukemia. 2016. PMID: 27001523

7

Selective usage of D-type cyclins in lymphoid malignancies.

Suzuki R, Kuroda H, Komatsu H, Hosokawa Y, Kagami Y, Ogura M, Nakamura S, Kodera Y, Morishima Y, Ueda R, Seto M. Suzuki R, et al. Among authors: seto m. Leukemia. 1999 Sep;13(9):1335-42. doi: 10.1038/sj.leu.2401485. Leukemia. 1999. PMID: 10482983

8

Molecular and immunological dissection of diffuse large B cell lymphoma: CD5+, and CD5- with CD10+ groups may constitute clinically relevant subtypes.

Harada S, Suzuki R, Uehira K, Yatabe Y, Kagami Y, Ogura M, Suzuki H, Oyama A, Kodera Y, Ueda R, Morishima Y, Nakamura S, Seto M. Harada S, et al. Among authors: seto m. Leukemia. 1999 Sep;13(9):1441-7. doi: 10.1038/sj.leu.2401487. Leukemia. 1999. PMID: 10482997 Clinical Trial.

9

Heterogeneous copy numbers of API2-MALT1 chimeric transcripts in mucosa-associated lymphoid tissue lymphoma.

Suguro-Katayama M, Suzuki R, Kasugai Y, Nakamura T, Suzuki H, Hosokawa Y, Shiku H, Nakamura S, Seto M. Suguro-Katayama M, et al. Among authors: seto m. Leukemia. 2003 Dec;17(12):2508-12. doi: 10.1038/sj.leu.2403179. Leukemia. 2003. PMID: 14562112

10

Immunohistochemical analysis of cyclin D1 protein in hematopoietic neoplasms with special reference to mantle cell lymphoma.

Nakamura S, Seto M, Banno S, Suzuki S, Koshikawa T, Kitoh K, Kagami Y, Ogura M, Yatabe Y, Kojima M, et al. Nakamura S, et al. Among authors: seto m. Jpn J Cancer Res. 1994 Dec;85(12):1270-9. doi: 10.1111/j.1349-7006.1994.tb02940.x. Jpn J Cancer Res. 1994. PMID: 7531681 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

944 results

Search Page

Filters